2005
[Prev Page]
[
Next Page
]
Page 1 of 17
1661 Messages
[
Date Index
]
[
Author Index
]
Pharmaceutical Sci-Tech
Seasons Greetings
,
A. D'Emanuele
Growth Promotion
,
Gil Zomber
<Possible follow-up(s)>
RE: Growth Promotion
,
Tony Cundell
RE: Growth Promotion
,
Scott Sutton
Growth Promotion
,
Andy Minkevich
RE: Growth Promotion
,
Scott Sutton
Monitoring storage condition for retention sample (AMC vs RH)
,
Yulianda Farraw
Re: ISO vs GMP
,
javadsha varaiya - rsc
<Possible follow-up(s)>
RE: ISO vs GMP
,
PB Consultancy
Assistance with obtaining journal articles that appeared over 10 years ago
,
Michael Anisfeld
Anaerobic monitoring
,
Lritchey
Tableting Specification Manual
,
vincent.surjana
GMP and cliinical trial material
,
Mark Celeste
<Possible follow-up(s)>
Re: GMP and cliinical trial material
,
NORMAN RABIN
RE: GMP and cliinical trial material
,
Post, Ivar
Anaerobic growth testing
,
carol_lampe
<Possible follow-up(s)>
RE: Anaerobic growth testing
,
Jennifer Muncy
ISO 17025
,
Atryzek, Vladimir
<Possible follow-up(s)>
Re: ISO 17025
,
Paul G. King
RE: ISO 17025
,
Bob Friedel
RE: ISO 17025
,
Atryzek, Vladimir
RE: ISO 17025
,
Bob Friedel
Sampling raw materials
,
Andy Minkevich
<Possible follow-up(s)>
RE: Sampling raw materials
,
Tony Cundell
Re: Sampling raw materials
,
Paul G. King
Re: Sampling raw materials
,
Stanley110
Re: Politicized GMPs?
,
Joseph T. Piechocki
<Possible follow-up(s)>
Re: Politicized GMPs?
,
Michael Brown
URS
,
Brooks
<Possible follow-up(s)>
RE: URS
,
Les Edwards
Re: URS
,
Jeremy.Court
Re: URS
,
Mark Celeste
Polysorbate 80 sampling and testing
,
Andy Minkevich
Deadly Medicine?
,
Michael Brown
Product Bubble point in integrity testing
,
Saritha Devi Polturi
<Possible follow-up(s)>
Re: Product Bubble point in integrity testing
,
h.van doorne
Re: Product Bubble point in integrity testing
,
etiennet
Re: Product Bubble point in integrity testing
,
Jim Tyrrell
RE: Product Bubble point in integrity testing
,
Alan.Moon
When should we passivate to remove rouge?
,
Robert Loss
<Possible follow-up(s)>
RE: When should we passivate to remove rouge?
,
McConlogue, Liam
RE: When should we passivate to remove rouge?
,
Thomas Peither
RE: When should we passivate to remove rouge?
,
Daryl Roll
RE: When should we passivate to remove rouge?
,
Daryl Roll
Re: When should we passivate to remove rouge?
,
GCampbell
Moisture Issue with Vacuum Dried Product
,
finbar oneill
<Possible follow-up(s)>
RE: Moisture Issue with Vacuum Dried Product
,
Søren Bogø
RE: Moisture Issue with Vacuum Dried Product
,
Tully, Roger
RE: Moisture Issue with Vacuum Dried Product
,
skachhwaha
RE: Moisture Issue with Vacuum Dried Product
,
Barry Giordano
RE: Moisture Issue with Vacuum Dried Product
,
finbar oneill
Decimals number of impurity in API
,
Hiroaki Matsumoto
<Possible follow-up(s)>
Re: Decimals number of impurity in API
,
Brian MATTHEWS
Re: Decimals number of impurity in API
,
Jim Tyrrell
Re: Decimals number of impurity in API
,
ravindra goyal
Re: Decimals number of impurity in API
,
himanshu
Ampoules integrity testing method
,
Papailiou Nikos
<Possible follow-up(s)>
Re: Ampoules integrity testing method
,
etiennet
Re: Ampoules integrity testing method
,
JFolan
Re: Decimal number of Impurity in API
,
r.kirsch
R: Ampoules integrity testing method
,
Mari, Alberto
Re: GMPs and Clinical Trial Material
,
william scruggs
<Possible follow-up(s)>
RE: GMPs and Clinical Trial Material
,
Michael Anisfeld
RE: GMPs and Clinical Trial Material
,
Mark Celeste
RE: GMPs and Clinical Trial Material
,
David Perkins
RE: GMPs and Clinical Trial Material
,
Miguel Castellanos
RE: GMPs and Clinical Trial Material
,
Nancy Fulginiti
RE: GMPs and Clinical Trial Material
,
Andrew Minkevich
RE: GMPs and Clinical Trial Material
,
Frank Rauschen
Antisera and clinical trials
,
Gil Zomber
Re: GMPs and CTM
,
William Scruggs
SIP requirements for temperature
,
Chip Schenk
<Possible follow-up(s)>
RE: SIP requirements for temperature
,
McConlogue, Liam
Re: SIP requirements for temperature
,
Jim Tyrrell
Expectations of Sanitation Effectiveness
,
Robert Rosenlof
FDA 2656
,
Rajagopal
Visual Inspection of uncoated tablets
,
ravindra goyal
Cleaning Reagents
,
Tom Smith
<Possible follow-up(s)>
Re: Cleaning Reagents
,
Bob Kirsch
Re: Cleaning Reagents
,
s.langford1
Re: Re: Cleaning Reagents
,
BIREN SONI
WFI Loop Temp
,
bens
<Possible follow-up(s)>
Re: WFI Loop Temp
,
NORMAN RABIN
RE: WFI Loop Temp
,
Kenyon, David [CNTUS]
RE: WFI Loop Temp
,
Pradeep Chakravarty - Claris
RE: WFI Loop Temp
,
Desjardins Claude
RE: WFI Loop Temp
,
Andrew Minkevich
RE: WFI Loop Temp
,
Scott Sutton
RE: WFI Loop Temp
,
Ogden, Bill
Environmental Monitoring for Clinical APIs
,
Cheryl Loomis
<Possible follow-up(s)>
Re: Environmental Monitoring for Clinical APIs
,
NORMAN RABIN
Raw material specifications and process validation
,
Jean-Philippe Cros
<Possible follow-up(s)>
Re: Raw material specifications and process validation
,
Paul G. King
Re: Raw material specifications and process validation
,
Dr Moustsfa Al Shammat
Re: Raw material specifications and process validation
,
BIREN SONI
Non-Sterile APIs
,
Miguel Castellanos
<Possible follow-up(s)>
RE: Non-Sterile APIs
,
Michael Anisfeld
re: Non-Sterile APIs
,
Ogden, Bill
Anti-static devices
,
Connie Hillenbrand
<Possible follow-up(s)>
Re: Anti-static devices
,
Bob Kirsch
[Prev Page]
[
Next Page
]
Page 1 of 17
1661 Messages
[
Date Index
]
[
Author Index
]
Mail converted by
MHonArc
2.3.3